JMPWA
GBT

JP Morgan Private Wealth Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-15,431
Closed -$1.05M – 2033
2022
Q3 		$1.05M Sell
15,431
-2,847
-16% -$157K ﹤0.01% 1107
2022
Q2 		$584K Sell
18,278
-1,460
-7% -$42.7K ﹤0.01% 1395
2022
Q1 		$684K Sell
19,738
-2,289
-10% -$68.4K ﹤0.01% 1387
2021
Q4 		$645K Sell
22,027
-1,196
-5% -$37K ﹤0.01% 1445
2021
Q3 		$592K Sell
23,223
-504
-2% -$14.8K ﹤0.01% 1434
2021
Q2 		$831K Sell
23,727
-13,574
-36% -$530K ﹤0.01% 1281
2021
Q1 		$1.52M Sell
37,301
-2,804
-7% -$129K ﹤0.01% 871
2020
Q4 		$1.74M Buy
40,105
+530
+1% +$26.1K 0.01% 790
2020
Q3 		$2.18M Buy
39,575
+18,640
+89% +$1.18M 0.01% 627
2020
Q2 		$1.32M Buy
20,935
+424
+2% +$29.1K 0.01% 707
2020
Q1 		$1.05M Buy
20,511
+10,188
+99% +$682K 0.01% 700
2019
Q4 		$821K Buy
10,323
+127
+1% +$7.53K ﹤0.01% 872
2019
Q3 		$495K Buy
10,196
+3,043
+43% +$159K ﹤0.01% 1009
2019
Q2 		$376K Sell
7,153
-1,794
-20% -$103K ﹤0.01% 1072
2019
Q1 		$474K Buy
8,947
+854
+11% +$42K ﹤0.01% 1058
2018
Q4 		$332K Sell
8,093
-4,595
-36% -$172K ﹤0.01% 1118
2018
Q3 		$482K Buy
12,688
+5,523
+77% +$245K ﹤0.01% 1086
2018
Q2 		$324K Hold
7,165
– – ﹤0.01% 1178
2018
Q1 		$346K Sell
7,165
-619
-8% -$34.5K ﹤0.01% 997
2017
Q4 		$306K Buy
7,784
+163
+2% +$6.09K ﹤0.01% 1048
2017
Q3 		$237K Buy
+7,621
New +$214K ﹤0.01% 1100

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

JP Morgan Private Wealth Advisors's GBT Position: Q4 2022 in Review

JP Morgan Private Wealth Advisors sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 15,431 shares — an estimated $1.05M sold.

JP Morgan Private Wealth Advisors first reported a position in GBT in Q3 2017 and held it in 21 quarters. The position peaked at $2.18M in Q3 2020. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • JP Morgan Private Wealth Advisors reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 15,431 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $1.05M.
  • JP Morgan Private Wealth Advisors first reported a position in Global Blood Therapeutics, Inc. in Q3 2017 and held it in 21 quarters.
  • JP Morgan Private Wealth Advisors's Global Blood Therapeutics, Inc. position peaked at $2.18M in Q3 2020.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.